DSV Panalpina A/S
22.1.2021 09:39:20 CET | Globenewswire | Press release
We expect to release the 2020 Annual Report of DSV Panalpina A/S in the morning of 10 February 2021. A webcast and conference call will be held at 13:00 CET.
At the call, CEO Jens Bjørn Andersen and CFO Jens Lund will present the 2020 Annual Report. The presentation will be followed by a Q&A session.
Date: 10 February 2021
Time: 13:00 CET
In order to attend the conference call, you may do one of the following:
a. Webcast
Go to investor.dsv.com or https://streams.eventcdn.net/dsv/full-year-2020-report/
b. Conference call
Participant dial-in telephone numbers:
DK +45 82 33 31 94
UK +44 (0) 333 300 9273
US +1 833 823 0586
No prior registration is required to attend the teleconference, but we recommend participants to dial in 10 minutes prior to the scheduled start time.
Contacts
Investor Relations
Flemming Ole Nielsen, tel. +45 43 20 33 92, flemming.o.nielsen@dsv.com
Frederikke Anna Linde, tel. +45 43 20 31 95, frederikke.a.linde@dsv.com
Mads Kristian Hofmeister, tel. +45 43 20 33 88, madskristian.hofmeister@dsv.com
Media
Maiken Riise Andersen, tel. +45 43 20 30 74, maiken.r.andersen@dsv.com
Yours sincerely,
DSV Panalpina A/S
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Elmet Group24.9.2026 03:18:35 CEST | Press release
The Elmet Group to Invest Approximately $125 Million in Masan High-Tech Materials to Strengthen Tungsten Supply Chain
TARK Games23.9.2026 23:13:36 CEST | Press release
Türkiye’s Indie PC Scene Breaks Out as BOMBANANA! Sells One Million Copies in Ten Days
Teva Pharmaceutical Industries Ltd23.9.2026 22:45:00 CEST | Press release
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET
Teva Pharmaceutical Industries Ltd23.9.2026 22:45:00 CEST | Press release
Teva Releases Q3 2026 Aide Memoire
Zymeworks Inc.23.9.2026 22:01:00 CEST | Press release
Zymeworks Completes Acquisition of Theravance Biopharma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
